| HOME >> MEDICINE >> TECHNOLOGY |
About the National Cancer Institute
The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
The NCI is a component of the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services (DHHS).
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare
business with more than 12,000 employees. For nearly three decades,
AstraZeneca has offered drug assistance programs side by side with
its medicines, and over the past five years, has provided over $3
billion in savings to more than 1 million patients throughout the
US and Puerto Rico. AstraZeneca has been named one of the "100 Best
Companies for Working Mothers" by Working Mother magazine and is
the only large pharmaceutical company named to FORTUNE magazine's
2007 list of "100 Best Companies to Work For." In 2006, for the
fifth consecutive year, Science magazine named AstraZeneca a "Top
Employer
'"/>